AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 280: H1039-H1050, 2001;
0363-6135/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheikh, F.
Right arrow Articles by Cattini, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheikh, F.
Right arrow Articles by Cattini, P. A.
Vol. 280, Issue 3, H1039-H1050, March 2001

Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts

Farah Sheikh1, David P. Sontag1, Robert R. Fandrich2, Elissavet Kardami2, and Peter A. Cattini1

1 Department of Physiology, University of Manitoba, Winnipeg, Manitoba, R3E 3J7; and 2 Department of Human Anatomy and Cell Science, Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada R2H 2A6

We generated transgenic (TG) mice overexpressing fibroblast growth factor (FGF)-2 protein (22- to 34-fold) in the heart. Chronic FGF-2 overexpression revealed no significant effect on heart weight-to-body weight ratio or expression of cardiac differentiation markers. There was, however, a significant 20% increase in capillary density. Although there was no change in FGF receptor-1 expression, relative levels of phosphorylated c-Jun NH2-terminal kinase and p38 kinase as well as of membrane-associated protein kinase C (PKC)-alpha and total PKC-epsilon were increased in FGF-2-TG mouse hearts. An isolated mouse heart model of ischemia-reperfusion injury was used to assess the potential of increased endogenous FGF-2 for cardioprotection. A significant 34-45% increase in myocyte viability, reflected in a decrease in lactate dehydrogenase released into the perfusate, was observed in FGF-2 overexpressing mice and non-TG mice treated exogenously with FGF-2. In conclusion, FGF-2 overexpression causes augmentation of signal transduction pathways and increased resistance to ischemic injury. Thus, stimulation of endogenous FGF-2 expression offers a potential mechanism to enhance cardioprotection.

fibroblast growth factor; transgenic mice; cardioprotection; Langendorff preparation


This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
S. Y. Lu, D. P. Sontag, K. A. Detillieux, and P. A. Cattini
FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development
Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1242 - C1249.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. L. House, S. J. Melhorn, G. Newman, T. Doetschman, and J. E. J. Schultz
The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H354 - H365.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kaneko, Y. Yonemitsu, T. Fujii, M. Onimaru, C.-H. Jin, M. Inoue, M. Hasegawa, T. Onohara, Y. Maehara, and K. Sueishi
A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1484 - H1492.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
A. Ponten, E. Bergsten Folestad, K. Pietras, and U. Eriksson
Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice
Circ. Res., November 11, 2005; 97(10): 1036 - 1045.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Filion and A. S. Popel
Intracoronary administration of FGF-2: a computational model of myocardial deposition and retention
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H263 - H279.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
E. Kardami, Z.-S. Jiang, S. K Jimenez, C. J Hirst, F. Sheikh, P. Zahradka, and P. A Cattini
Fibroblast growth factor 2 isoforms and cardiac hypertrophy
Cardiovasc Res, August 15, 2004; 63(3): 458 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. K Jimenez, F. Sheikh, Y. Jin, K. A Detillieux, J. Dhaliwal, E. Kardami, and P. A Cattini
Transcriptional regulation of FGF-2 gene expression in cardiac myocytes
Cardiovasc Res, June 1, 2004; 62(3): 548 - 557.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Z.-S. Jiang, W. Srisakuldee, F. Soulet, G. Bouche, and E. Kardami
Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion
Cardiovasc Res, April 1, 2004; 62(1): 154 - 166.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
F. Eefting, B. Rensing, J. Wigman, W. J. Pannekoek, W. M. Liu, M. J. Cramer, D. J Lips, and P. A Doevendans
Role of apoptosis in reperfusion injury
Cardiovasc Res, February 15, 2004; 61(3): 414 - 426.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. L. House, C. Bolte, M. Zhou, T. Doetschman, R. Klevitsky, G. Newman, and J. E. J. Schultz
Cardiac-Specific Overexpression of Fibroblast Growth Factor-2 Protects Against Myocardial Dysfunction and Infarction in a Murine Model of Low-Flow Ischemia
Circulation, December 23, 2003; 108(25): 3140 - 3148.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J. A. Holt, G. Luo, A. N. Billin, J. Bisi, Y. Y. McNeill, K. F. Kozarsky, M. Donahee, D. Y. Wang, T. A. Mansfield, S. A. Kliewer, et al.
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
Genes & Dev., July 1, 2003; 17(13): 1581 - 1591.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. A. Detillieux, F. Sheikh, E. Kardami, and P. A. Cattini
Biological activities of fibroblast growth factor-2 in the adult myocardium
Cardiovasc Res, January 1, 2003; 57(1): 8 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. T. A. Meij, F. Sheikh, S. K. Jimenez, P. W. Nickerson, E. Kardami, and P. A. Cattini
Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H547 - H555.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-S. Jiang, R. R. Padua, H. Ju, B. W. Doble, Y. Jin, J. Hao, P. A. Cattini, I. M. C. Dixon, and E. Kardami
Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1071 - H1080.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J.L. Mehta, H.J. Chen, and D.Y. Li
Protection of Myocytes From Hypoxia-Reoxygenation Injury by Nitric Oxide Is Mediated by Modulation of Transforming Growth Factor-{beta}1
Circulation, May 7, 2002; 105(18): 2206 - 2211.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online